Skip to content
  • Saturday, 13 June 2026
  • 1:30 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials
Pharmaceutical R&D

Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials

Teuku Ryan Jun 3, 2026 0

Contraline, a pioneering biotechnology firm backed by Google Ventures, has successfully closed a substantial $92.5 million Series B financing round.…

Read More
Science News: A Century of Empowering Public Understanding of Science, Medicine, and TechnologyTWiV 1288: Clinical update with Dr. Daniel GriffinRising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical LabsResearchers at the University of Konstanz Identify a New Type of Contactless Magnetic Friction and the Breakdown of Amontons Law
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Stanford Medicine Study Identifies Gerozyme Inhibitor Capable of Regenerating Knee Cartilage and Reversing Osteoarthritis DamageApplication Note: Optimizing alternative vessel formats for transient protein production in the Expi293 PRO Expression SystemJ&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth PushCancer Driving Mutations in Brain Immune Cells Linked to Alzheimer’s Disease Progression and Risk
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Stanford Medicine Study Identifies Gerozyme Inhibitor Capable of Regenerating Knee Cartilage and Reversing Osteoarthritis Damage
Dwi Wanna Jun 13, 2026
Biotech & Genetic Research
Application Note: Optimizing alternative vessel formats for transient protein production in the Expi293 PRO Expression System
Jia Lissa Jun 13, 2026
Laboratory Automation & Robotics
J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push
Lana Keisha Jun 13, 2026
Neuroscience & Brain Research
Cancer Driving Mutations in Brain Immune Cells Linked to Alzheimer’s Disease Progression and Risk
Rifan Muazin Jun 13, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ